d_sanitaria_acuerdo marco_ medicamentos exclusivos III
TED · 403479-2026Award noticeawardedNo deadline given
Value
Estimated—
Awarded—
WinnerMERCK SL | ASTELLAS PHARMA SA | TAKEDA FARMACEUTICA ESPAÑA SA | NOVARTIS FARMACEUTICA, SA | OTSUKA PHARMACEUTICAL SA | ABBVIE SPAIN, SLU | SANOFI AVENTIS SA
Who already wins at this buyer
Firms with recorded awards from Servicio de Salud - Servicios Centrales in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| ESSITY SPAIN SLU | 4 | — | 2026-07-20 |
| REDDY PHARMA IBÉRIA S.A. | TARBIS FARMA S.L. | AUROVITAS SPAIN S.A.U. | ACCORD HEALTHCARE SL | VIVANTA GENERICS S.R.O. SUCURSAL EN ESPAÑA | ABBVIE SPAIN S.L.U. | BAXTER SL | LABORATORIOS NORMON S.A. | TEVA PHARMA | Celltrion Farmaceutica España SL | 1 | €3,344,037 | 2026-05-13 |
| SANOFI AVENTIS SA | ASTRAZENECA FARMACEUTICA SPAIN SA | 1 | €775,432 | 2026-07-21 |
| TELEFONICA SOLUCIONES INFORMATICA Y COMUNICACIONES ESPAÑA SA | 1 | €605,090 | 2026-05-13 |
| MEDTRONIC IBERICA, SA | 1 | €300,000 | 2026-06-25 |
Full buyer profile: what Servicio de Salud - Servicios Centrales buys and who wins it →
CPV codes
33690000 Medical equipment & pharmaceuticalsDescription
d_sanitaria_acuerdo marco_ medicamentos exclusivos III
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-05-13 | d_sanitaria_varios medicamentos | Servicio de Salud - Servicios Centrales ES | 97% |
| 2026-07-03 | Acuerdo Marco del Suministro de MEDICAMENTOS I | Consorci de Salut i d'Atenció Social de Catalunya ES | 93% |
| 2026-06-30 | Material sanitario general diverso | Gerencia Sector Sanitario de Zaragoza 3 ES | 93% |
| 2026-06-10 | Acuerdo Marco del Suministro de MEDICAMENTOS ANTIRRETROVIRALES | Consorci de Salut i d'Atenció Social de Catalunya ES | 93% |
| 2026-06-09 | Acuerdo Marco del Suministro de MEDICAMENTOS ONCOLÓGICOS | Consorci de Salut i d'Atenció Social de Catalunya ES | 92% |
| 2026-07-15 | ACUERDO MARCO DE SUMINISTRO DE MEDICAMENTOS ONCOLÓGICOS | Consorci de Salut i d'Atenció Social de Catalunya ES | 92% |